Type I and type III are the most abundant collagens in the lung, The a
im of our study was to compare type I and III procollagen peptides in
sera of sarcoid patients. Sixty eight patients with sarcoidosis were s
tudied (19 with newly recognized disease, 7 with relapsing disease, 15
with chronic disease, and 27 in stable remission), Thirty healthy vol
unteers served as controls, The levels of procollagen I and III peptid
es were determined by radioimmunoassay, Angiotensin-converting enzyme
(ACE) level was evaluated by means of a colorimetric assay. In patient
s with newly recognized sarcoidosis, both serum procollagen I and IU.
peptide levels were increased with respect to controls (p=0.0014 and p
<0.00001, respectively), There was a poor correlation between levels o
f procollagen I and III (r=0.26), whereas there was a closer correlati
on between procollagen III and ACE (r=0.69), Procollagen I peptide lev
el did not identify patients in roentgenological stage III. In conclus
ion, in patients with newly recognized sarcoidosis there is a signific
ant increase in the serum level of procollagen I peptide, However, pro
collagen I peptide is not a marker of sarcoid patients with fibrosis,
ie. stage III disease Its clinical cal usefulness seems to be weaker t
han that of procollagen III peptide.